drugset / Trial / NCT00820911
Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will assess safety and efficacy of AEB071 combined with everolimus in a CNI-free (calcineurin inhibitor) regimen in renal transplant recipients.
Timeline
- Start
- 2008-09
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclosporine | Peptide | — | — |
| Subject | sotrastaurin | Small molecule | 200 mg | — |
| Subject | sotrastaurin | Small molecule | 300 mg | — |
| Background | Everolimus | Small molecule | — | — |
Indications
No indication recorded.